CST7
CST7, also known as cystatin F or leukocystatin, is a glycosylated type 2 cystatin that inhibits cysteine proteases. It is proposed to contribute to immune regulation through inhibition of a target specific to the haematopoietic system. Browse Assay Genie's current range of CST7 research reagents below, or read on for the biology behind the target.
CST7 (cystatin F) is a cysteine protease inhibitor. It inhibits papain and cathepsin L, although with lower affinity than other cystatins. Its more distinctive proposed role is in immune regulation: it may act by inhibiting a unique target in the haematopoietic system, which sets it apart from the broader cystatin family. The identity of that target is not defined in the sources used here.
The CST7 gene encodes a glycosylated protein that belongs to the cystatin family. Within the HGNC classification it sits in the type 2 cystatins. These are cysteine proteinase inhibitors found in a variety of human fluids and secretions, and UniProt annotates the CST7 protein as both secreted and present in the cytoplasm. The wider cystatin superfamily contains proteins with multiple cystatin-like sequences. Some members are active cysteine protease inhibitors, while others have lost, or perhaps never acquired, this activity. Three inhibitory families are recognised: the type 1 cystatins (stefins), the type 2 cystatins and the kininogens.
HGNC records the previous name of the gene as cystatin F (leukocystatin), and the approved name is now cystatin F. Expression of the protein has been observed in various human cancer cell lines established from malignant tumours, which is one reason it is studied in cancer biology as well as immunology. The mouse ortholog is Cst7. Researchers working on CST7 often compare it with other type 2 cystatins to understand how inhibitory strength and target selectivity differ across the group.
CST7 may regulate immunity by inhibiting a unique target in the haematopoietic system, making it a focus for studies of immune cell biology.
CST7 inhibits papain and cathepsin L with lower affinity than other cystatins, offering a comparison point for inhibitor selectivity.
Protein expression has been observed in various human cancer cell lines established from malignant tumours, prompting investigation of its role in cancer.
As a glycosylated type 2 cystatin, CST7 helps researchers explore how secreted protease inhibitors diverge in function within the superfamily.
CST7 is a cysteine protease inhibitor that inhibits papain and cathepsin L, though with lower affinity than other cystatins. It may also play a role in immune regulation by inhibiting a unique target in the haematopoietic system, according to UniProt and NCBI Gene.
The approved HGNC name is cystatin F, and the previous name was cystatin F (leukocystatin). No alternative gene symbols are listed. UniProt names the protein Cystatin-F, and it is placed in the type 2 cystatin gene group.
A mouse ortholog, Cst7, is recorded. NCBI Gene notes that CST7 protein expression has been observed in various human cancer cell lines established from malignant tumours. Check the datasheet of any product for its validated reactivity.
Other cystatin family members and related protease inhibitors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O76096; product specifications from Assay Genie datasheets.